Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC inhibition
Marika Massaro*,,
Aida Habib,,
Laura Lubrano,
Serena Del Turco,
Guido Lazzerini,
Todd Bourcier¶,
Babette B. Weksler||, and
Raffaele De Caterina**,
*Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, 73100 Lecce, Italy; Departments of Biochemistry and Internal Medicine, American University of Beirut, Beirut, Lebanon; Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, 56124 Pisa, Italy; ¶Department of Anesthesia, Brigham and Women's HospitalHarvard Medical School, Boston, MA 02115; ||Weill Medical College of Cornell University, New York, NY 10021; and **Institute of Cardiology and Center of Excellence on Aging, "Gabriele d'Annunzio" University, 66100 Chieti, Italy
Edited by Charles A. Dinarello, University of Colorado Health Sciences Center, Denver, CO, and approved July 25, 2006
Received for publication January 13, 2006.
Abstract:
A high intake of the omega-3 fatty acid docosahexaenoate [docosahexaenoicacid (DHA)] has been associated with systemic antiinflammatoryeffects and cardiovascular protection. Cyclooxygenase (COX)-2is responsible for the overproduction of prostaglandins (PG)at inflammatory sites, and its expression is increased in atheroma.We studied the effects of DHA on COX-2 expression and activityin human saphenous vein endothelial cells challenged with proinflammatorystimuli. A 24-h exposure to DHA reduced COX-2 expression andactivity induced by IL-1, without affecting COX-1 expression.DHA effect depended on the NF-B-binding site in the COX-2 promoter.EMSAs confirmed that DHA attenuated NF-B activation. BecauseMAPK, PKC, and NAD(P)H oxidase all participate in IL-1-mediatedCOX-2 expression, we also tested whether these enzymes wereinvolved in DHA effects. Western blots showed that DHA blockednuclear p65 NF-B subunit translocation by decreasing cytokine-stimulatedreactive oxygen species and ERK1/2 activation by effects onboth NAD(P)H oxidase and PKC activities. Finally, to addressthe question whether DHA itself or DHA-derived products wereresponsible for these effects, we inhibited the most importantenzymes involved in polyunsaturated fatty acid metabolism, showingthat 15-lipoxygenase-1 products mediate part of DHA effects.These studies provide a mechanistic basis for antiinflammatoryand possibly plaque-stabilizing effects of DHA
Author contributions: B.B.W. and R.D.C. designed research; M.M.,A.H., L.L., S.D.T., G.L., and T.B. performed research; M.M.,A.H., B.B.W., and R.D.C. analyzed data; and B.B.W. and R.D.C.wrote the paper.
Conflict of interest statement: R.D.C. has received researchsupport and honoraria for lecturing on omega-3 fatty acids incardiovascular disease through Pharmacia-Pfizer (Milan, Italy),Società Prodotti Antibiotici (SPA; Milan, Italy), Sigma-Tau(Pomezia, Italy), and Pronova (Lysaker, Norway).
To whom correspondence should be addressed. E-mail: rdecater{at}unich.it
Pivotal Role of Protein Kinase C{delta} in Angiotensin II-Induced Endothelial Cyclooxygenase-2 Expression: A Link to Vascular Inflammation.
S. L. Wong, C. W. Lau, W. T. Wong, A. Xu, C. L. Au, C. F. Ng, S. S. M. Ng, M. Gollasch, X. Yao, and Y. Huang (2011)
Arterioscler Thromb Vasc Biol
31, 1169-1176
|Abstract »|Full Text »|PDF »
Docosahexaenoic Acid Improves the Nitroso-Redox Balance and Reduces VEGF-Mediated Angiogenic Signaling in Microvascular Endothelial Cells.
N. Matesanz, G. Park, H. McAllister, W. Leahey, A. Devine, G. E. McVeigh, T. A. Gardiner, and D. M. McDonald (2010)
Invest. Ophthalmol. Vis. Sci.
51, 6815-6825
|Abstract »|Full Text »|PDF »
Novel Lipid Mediators Promote Resolution of Acute Inflammation: Impact of Aspirin and Statins.
Blood Eicosapentaenoic and Docosahexaenoic Acids Predict All-Cause Mortality in Patients With Stable Coronary Heart Disease: The Heart and Soul Study.
J. V. Pottala, S. Garg, B. E. Cohen, M. A. Whooley, and W. S. Harris (2010)
Circ Cardiovasc Qual Outcomes
3, 406-412
|Abstract »|Full Text »|PDF »
PPAR{gamma} agonists inhibit angiogenesis by suppressing PKC{alpha}- and CREB-mediated COX-2 expression in the human endothelium.
E. Scoditti, M. Massaro, M. A. Carluccio, A. Distante, C. Storelli, and R. De Caterina (2010)
Cardiovasc Res
86, 302-310
|Abstract »|Full Text »|PDF »
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
M. Massaro, A. Zampolli, E. Scoditti, M. A. Carluccio, C. Storelli, A. Distante, and R. De Caterina (2010)
Cardiovasc Res
86, 311-320
|Abstract »|Full Text »|PDF »
Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism.
K. Ohashi, N. Ouchi, K. Sato, A. Higuchi, T.-o Ishikawa, H. R. Herschman, S. Kihara, and K. Walsh (2009)
Mol. Cell. Biol.
29, 3487-3499
|Abstract »|Full Text »|PDF »
Eicosapentaenoic Acid Improves Imbalance between Vasodilator and Vasoconstrictor Actions of Endothelium-Derived Factors in Mesenteric Arteries from Rats at Chronic Stage of Type 2 Diabetes.
T. Matsumoto, N. Nakayama, K. Ishida, T. Kobayashi, and K. Kamata (2009)
J. Pharmacol. Exp. Ther.
329, 324-334
|Abstract »|Full Text »|PDF »
Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostate Cancer Risk.
V. Fradet, I. Cheng, G. Casey, and J. S. Witte (2009)
Clin. Cancer Res.
15, 2559-2566
|Abstract »|Full Text »|PDF »
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation.
L. Wang, R. Gill, T. L. Pedersen, L. J. Higgins, J. W. Newman, and J. C. Rutledge (2009)
J. Lipid Res.
50, 204-213
|Abstract »|Full Text »|PDF »
Evaluation of lipid profiles and the use of omega-3 essential Fatty Acid in professional football players..
A. Yates, J. Norwig, J. C. Maroon, J. Bost, J. P. Bradley, M. Duca, D. A. Wecht, R. Grove, A. Iso, I. Cobb, et al. (2009)
Sports Health: A Multidisciplinary Approach
1, 21-30
|Abstract »|Full Text »|PDF »
Electrophilic Cyclopentenone Neuroprostanes Are Anti-inflammatory Mediators Formed from the Peroxidation of the {omega}-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid.
E. S. Musiek, J. D. Brooks, M. Joo, E. Brunoldi, A. Porta, G. Zanoni, G. Vidari, T. S. Blackwell, T. J. Montine, G. L. Milne, et al. (2008)
J. Biol. Chem.
283, 19927-19935
|Abstract »|Full Text »|PDF »
15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation.
X. Zuo, L. Shen, J.-P. Issa, O. Moy, J. S. Morris, S. M. Lippman, and I. Shureiqi (2008)
FASEB J
22, 1981-1992
|Abstract »|Full Text »|PDF »
Signaling pathways modulated by fish oil in salt-sensitive hypertension.
M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, J. Cheng, H. K. H. Keryakos, K. A. Nath, and J. P. Grande (2008)
Am J Physiol Renal Physiol
294, F1323-F1335
|Abstract »|Full Text »|PDF »
Cholesterol Sensitivity of Endogenous and Myristoylated Akt.
R. M. Adam, N. K. Mukhopadhyay, J. Kim, D. Di Vizio, B. Cinar, K. Boucher, K. R. Solomon, and M. R. Freeman (2007)
Cancer Res.
67, 6238-6246
|Abstract »|Full Text »|PDF »
n-3 Fatty Acids in the Treatment of Diabetic Patients: Biological rationale and clinical data.
R. De Caterina, R. Madonna, A. Bertolotto, and E. B. Schmidt (2007)
Diabetes Care
30, 1012-1026
|Full Text »|PDF »